Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | 13 | 0 | 1 | 0 | €21.60 | €80.10 | 270.833% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €74.32 | €80.00 | 7.643% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 5 | 0 | €62.00 | €79.55 | 28.313% |
| Henry Schein Inc. | 12 | 1 | 1 | 0 | €67.48 | €79.48 | 17.781% |
| Incyte Corp. | 12 | 2 | 3 | 0 | €52.88 | €78.42 | 48.303% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €76.50 | €75.94 | -0.737% |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 1 | 0 | €62.50 | €74.65 | 19.432% |
| Boston Scientific | 47 | 0 | 10 | 0 | €70.00 | €73.22 | 4.604% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €39.23 | €70.00 | 78.458% |
| Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €72.00 | €69.00 | -4.167% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €21.80 | €68.78 | 215.501% |
| LivaNova plc | 9 | 0 | 3 | 0 | €55.50 | €66.59 | 19.987% |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €58.50 | €66.53 | 13.724% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €68.20 | €65.00 | -4.692% |
| Galmed Pharmaceuticals Ltd. | 8 | 0 | 4 | 0 | €0.37 | €64.51 | 17240.054% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €23.67 | €60.55 | 155.826% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 0 | 0 | €51.70 | €57.50 | 11.219% |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | €34.80 | €56.62 | 62.693% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €50.63 | €55.00 | 8.631% |
| Radnet Inc. | 9 | 3 | 2 | 0 | €54.00 | €54.58 | 1.075% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €23.06 | €52.03 | 125.607% |
| Halozyme Therapeutics Inc. | 14 | 0 | 2 | 0 | €41.95 | €50.33 | 19.983% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €41.60 | €50.00 | 20.192% |
| Bayer AG | 15 | 1 | 1 | 0 | €28.40 | €50.00 | 76.087% |
| Fresenius Medical Care AG & Co KGaA ST | 4 | 0 | 0 | 0 | €39.63 | €50.00 | 26.167% |